智通财经网·2025-10-29 02:41Core Insights - NVIDIA's CEO announced collaborations with Johnson & Johnson and Eli Lilly to enhance existing products and develop new therapies using NVIDIA's technology [1] - Johnson & Johnson is utilizing NVIDIA's products to train surgical robots and simulate surgical processes through "digital twin" technology, aiming for unprecedented precision in minimally invasive surgeries [1] - NVIDIA and Eli Lilly are partnering to create a supercomputer that will serve as an "AI factory" for drug discovery and improving drug production processes [1] Group 1 - Johnson & Johnson is training surgical robots with NVIDIA's technology, which will enable them to perform minimally invasive surgeries with high precision [1] - The supercomputer being developed with Eli Lilly will be the first based on the Blackwell architecture and will feature over 1,000 B300 GPUs [1] - Eli Lilly's AI Chief emphasized the importance of embedding intelligence at every workflow level to enhance understanding of biological patterns and disease [1]